Genentech, Inc. (NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BIIB) today announced that a Phase II/III study of Rituxan® (rituximab) for primary-progressive multiple sclerosis (PPMS) did not meet its primary endpoint as measured by the time to   more »

Sometimes people with MS find they feel guilty, as if they have let their family and friends down or are somehow responsible for developing the condition. They may also feel guilty if they think   more »